Final analysis of camrelizumab plus chemotherapy for untreated advanced or metastatic esophageal squamous cell carcinoma: The ESCORT-1st trial
Ming-Ming He(Sun Yat-sen University), Hui Luo(Sun Yat-sen University), Ying Cheng(Jilin Province Tumor Hospital), Yi Ba(Tianjin Medical University Cancer Institute and Hospital), Zuoxing Niu(Shandong Tumor Hospital), Jun Wang(Hebei Medical University), Kuaile Zhao(Shanghai Medical College of Fudan University), Jifeng Feng(Jiangsu Cancer Hospital), Jing Huang(Chinese Academy of Medical Sciences & Peking Union Medical College), X.-C. Zhang(Beijing Institute of Technology), Yuxian Bai(Harbin Medical University), Xiaodong Zhang(The University of Texas MD Anderson Cancer Center), Dong Wang(Zhejiang Chinese Medical University), Zhiqiang Wang(Sun Yat-sen University), Zhihua Liu(Shanghai Jiao Tong University), Ying Liu(Chongqing University), Li Zhang(Fourth Hospital of Changsha), Song Li, Zhendong Chen(Anhui Medical University), Kangsheng Gu(Anhui Medical University), Jiancheng Li(Fujian Provincial Cancer Hospital), Wanqin Zeng(Jiangsu Hengrui Medicine (China)), Rui‐Hua Xu(Sun Yat-sen University), Zhichao Fu(South China Agricultural University), Xuhong Min(Xi'an Chest Hospital), Qing-Xia Fan(First Affiliated Hospital of Zhengzhou University), Teng Mao(Bristol-Myers Squibb (Germany)), Lin Wu(Hunan Cancer Hospital), Zhen Sheng(Jiangsu Hengrui Medicine (China)), Jin Lu(Sichuan Cancer Hospital), Shegan Gao(First Affiliated Hospital of Henan University of Science and Technology), Helong Zhang(Shanghai International Studies University)
Cited by 32
Related Papers
A Perivascular Origin for Mesenchymal Stem Cells in Multiple Human Organs
|Cell stem cell|2008|4k
Circular RNA: metabolism, functions and interactions with proteins
|Molecular Cancer|2020|1.6k